Chief Financial Officer

Group Chief Financial Officer (CFO) 5 million+ RMB

Recruitment Background

1. Job Background: This position is the core financial position of the group.

2. Reporting to the CEO – One of the company's core founders, a member of the group's core management team, deeply involved in the company's strategic operations and capital management.

2. Company – A Shanghai Stock Exchange listed company in 2015, currently operating a "Big Health Closed-Loop Ecosystem" encompassing:

Retail Direct-Operated Pharmacies

Franchise System

New Retail

Pharmaceutical Industry

Pharmaceutical Wholesale and other business formats.Organizational Structure includes:

Group Headquarters

10 Provincial Sub-Companies

Overall Business Complexity:

1. Organizational coordination difficulty and management scale are both relatively large.

2. Team Situation: The group's overall finance team consists of 340 people. This includes: Group Finance Center (260+ people)

Finance Shared Services Center (200+ people)

Finance BP Teams in 10 Provincial Branches

Job Requirements: Strong management skills for large-scale groups, especially experience in shared services, group-wide control, and business collaboration.

I. Basic Information

Base: Changsha

Reporting to: CEO and one of the founders

Emphasis on energy and sustained performance

Education: Full-time Bachelor's degree or above, excellent academic background

II. Core Capabilities and Qualities

Responsibilities: CFO, overseeing: 1. Investment and Financing; 2. Mergers and Acquisitions; 3. Business Integration, etc.Core Capability Requirements

1. Experience as the overall head of an A-share listed company or a company with a market capitalization of over 20 billion RMB, familiar with capital market rules, information disclosure, and compliance requirements, and capable of building business integration capabilities.

Outstanding achievements in business operations.

Experience in managing a multi-business, multi-accounting group, with practical experience in mergers and acquisitions integration, investment and financing, and capital pool operations.

Successfully promoted the implementation of digitalization and business integration projects, possessing strong business management awareness and organizational drive.

Managed over 200... Teams of 10 or more, capable of managing large-scale shared service systems. Personal traits and preferences: Grounded, practical, patient, and able to work on the front lines of the industry; strong business integration and implementation capabilities; ability to overcome challenges and drive collaboration in complex organizations; clear understanding of mismatches.

III. Benchmarking Industry: No industry restrictions; no To C/To B restrictions; suitable for multi-business group companies; priority given to candidates with complex organizations, multiple business segments, and rapid expansion backgrounds.

IV. Other Supplements:

Service system/shared service model; more operational-oriented CFO than traditional control-oriented. CFO candidate should possess both capital market expertise and business management skills.

V. Compensation Structure: Total Annual Salary: 5 million+ RMB (including stock options)

Our Client, Key Data Indicators for the Pharmaceutical Retail Industry

2025 Revenue: 29 billion RMB

2025 Number of Stores: 14,831

2026 Q1 Revenue: 6.085 billion RMB

2026 Q1 Number of Stores: 14,943

Company Core Management Introduction

I. Core Performance

Operating Revenue: RMB 24.433 billion, a year-on-year increase of 1.54%

Net Profit Attributable to Shareholders: RMB 1.678 billion, a year-on-year increase of 9.81%

Net Profit Excluding Deductible Items: RMB 1.612 billion, a year-on-year increase of 7.65%

Core Analysis

Revenue growth slowed, but profits maintained growth, indicating that the company has entered the "quality and efficiency improvement, profit-first" stage.

II.1 Store Scale and Expansion Strategy

Total Stores: 14,831

Directly Operated Stores: 10,518

Franchised Stores: 4,313

New 694 new stores opened

547 stores closed

Net increase of 147 stores

Core Analysis: Shifting from pursuing quantitative expansion to optimizing structure and improving the quality of individual stores, the franchise model is developing rapidly.

O2O Membership and New Retail Capabilities

Total Membership: 116 millionOfficial Website Fans: 17.25 million+

Internet Revenue: RMB 2.993 billion (including tax)

Of which:

O2O: RMB 2.094 billion

B2C: RMB 899 million

Core Analysis: Membership assets have formed a huge moat, integrating online and offline channels. Chemical Energy Continues to Strengthen

2. Outflow of Products and Layout of Specialized Pharmacies

Hospital-Adjacent Pharmacies: 688

DTP Specialized Pharmacies: 316

Dual-Channel Medical Insurance Pharmacies: 251

Cooperative Prescription Drug Suppliers: Nearly 200

Self-Established Clinics: 145

Self-Established Internet Hospitals: More than 10

Core Interpretation

Gongzheng is Elevating from a Traditional Retail Pharmacy to a "Medical + Pharmaceutical

+ Insurance + Health Service" Platform

2. First Quarter Performance (2026)

Revenue: NT$6.085 billion, a year-on-year increase of 1.26%

Net Profit Attributable to Shareholders: Nearly NT$500 million Year-on-year increase of 11.14%

Net profit excluding tax: 493 million yuan, year-on-year increase of 12.57%

Store Status

Total number of stores: 14,943

Net increase of 112 storesCore Analysis

Revenue continues to grow steadily, profit growth continues to outpace revenue growth, and operating quality continues to improve.

Overall, in a nutshell, Yifeng Pharmacy has moved from the "era of rapid store opening" to the "era of high-quality growth," and its core value is shifting from the number of stores to membership operation efficiency.

Single-store profitability

Outflow capacity and

Digital new retail capabilities.